openPR Logo
Press release

Nanoemulsion Market Set to Surge Significantly During 2025

09-28-2017 08:53 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Nanoemulsion Market Set to Surge Significantly During 2025

A report by Transparency Market Research finds that big international players in the global market for Nanoemulsion are keen to tap into the developing nations’ market that offer ample room for growth.

Buoyed by demand from both developed and developing nations, the TMR report projects the global Nanoemulsion market to rise at a 9.2% CAGR during the period between 2017 and 2025. Expanding at this pace, the market which was worth US$6.78 bn in 2016 will probably become worth US$14.91 bn by 2025.

View and Download TOC of Nanoemulsion Market Research Report@ https://www.transparencymarketresearch.com/report-toc/15473

Increasing Research Activities Boosts North America Market

Depending upon the type of drugs, the global market for Nanoemulsion can be segmented into steroids, anesthetics, NSAIDs, antiretroviral, antimicrobials, immunosuppressant, vasodilators, etc. Among them, the segment of NSAIDs will likely gain maximum share by outpacing all others vis-à-vis growth rate. By 2025, the segment of NSAIDs will rake in a revenue of US$2.470 bn. The high growth of the segment is due to the increasing use nanoemulsion formulation in topical and other drug administration routes for more efficient drug delivery allowing for rapid penetration.

Geography-wise, the key segments of the global market for Nonoemulsion are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA). Among them, North America held the leading share of 39.7% in 2016. The market in the region is predicted grow at a healthy clip in the upcoming years as well on account of the increasing demand generated by a well-established pharmaceutical and biotechnology industry, increasing research activities, increasing prevalence of chronic disorders, and increased demand for highly efficient drug delivery module for target specific treatment of disorders.

Emergence of Better Products Benefits Market

Serving to majorly fuel the global market for Nanoemulsion is the rapid technological progress in the pharmaceutical and biotechnology industry, rising instances of chronic diseases, increasing awareness about their treatments, growing demand for more target specific drug delivery systems, and supportive policies of governments. Emergence of technologically advanced new products is also having a positive impact on the global Nanoemulsion market.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15473

The other factors responsible for the growth the market include increasing healthcare infrastructure, increasing economic stability, increasing participation of major market players in in developing economies such as Latin America and the Middle East and Africa. Increasing demand for more efficient drug delivery systems and increasing research and development is expected to drive the market during the forecast period.

“As the Nanoemulsions do not undergo flocculation or sedimentation they are ideal for use in baby-care wipes or make-up removal applications. This is another growth driver in the market. As nanoemulsions are non-toxic and non-irritant they are widely used in skin care cosmetics. However, the cost of nanoemulsions preparation can prove to be a deterrent to the nanoemulsions market,” explains the lead analyst of the report.

Some of the key players operating in the global market for Nanoemulsion are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG. Many of them already have a robust pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases.

Buy Full Nanoemulsion Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=15473<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nanoemulsion Market Set to Surge Significantly During 2025 here

News-ID: 744945 • Views: 291

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Nanoemulsion

Nanoemulsion Market 2017 Outlook
In this report, the global Nanoemulsion market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, grwing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nanoemulsion in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Get
Nanoemulsion Market Projected to Reach US$14.91 bn by 2025
Global Nanoemulsion Market: Snapshot There are various ways in which established players are trying to increase their stronghold over the global market for Nanoemulsion. Expanding outreach in developing markets that offer enormous opportunities to grow is one of them. Besides, they also have a strong pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases. View Report- https://www.transparencymarketresearch.com/nanoemulsion-market.html There are many factors currently boosting the global Nanoemulsion
Nanoemulsion Market Opportunity Analysis, 2018-2026
Nanoemulsion is the process of suspension of minimicrons of globules of one liquid to other liquids that are immiscible to each other. Nanoemulsions are oil-in-water emulsions with mean size ranging from 50 to 1000 nm. Average size of a droplet is between 100 and 500 nm. Nanoemulsions are made from surfactants approved for human consumption and food substances that are recognized as safe by the U.S. FDA. Nanoemulsion can be
Nanoemulsion Market to Reach US$14.91 bn by 2025
Global Nanoemulsion Market: Snapshot There are various ways in which established players are trying to increase their stronghold over the global market for Nanoemulsion. Expanding outreach in developing markets that offer enormous opportunities to grow is one of them. Besides, they also have a strong pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases. View Report- https://www.transparencymarketresearch.com/nanoemulsion-market.html There are many factors currently boosting the global Nanoemulsion
Nanoemulsion Market Foreseen to Grow Exponentially by 2025
A report by Transparency Market Research finds that big international players in the global market for Nanoemulsion are keen to tap into the developing nations’ market that offer ample room for growth. Some of the key players operating in the global Nanoemulsion Market are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG.
Nanoemulsion Market to Garner Brimming Revenues by 2025
A report by Transparency Market Research finds that big international players in the global market for Nanoemulsion are keen to tap into the developing nations’ market that offer ample room for growth. Read Report Overview - https://www.transparencymarketresearch.com/nanoemulsion-market.html Buoyed by demand from both developed and developing nations, the TMR report projects the global Nanoemulsion market to rise at a 9.2% CAGR during the period between 2017 and 2025. Expanding at this pace, the